Pfizer spends billions to develop new drugs. It’s not satisfied. So it’s launching a startup

methamphetaminedertrick / Pixabay

 

There’s a popular theory about the limitations of global pharma companies: For all their skyscrapers and strategy reviews and private jets, they’re simply too knotted up in bureaucracy to realize how many great drugs are gathering dust in their vaults. Now, the biggest of Big Pharma is out do do something about that. Pfizer, home to…

For exclusive info on hedge funds and the latest news from value investing world at only a few dollars a month check out ValueWalk Premium right here.

Multiple people interested? Check out our new corporate plan right here (We are currently offering a major discount)



About the Author

Guest Post
If you are interested in contributing to ValueWalk on a regular or one time basis - email us at info(at)valuewalk.com

Be the first to comment on "Pfizer spends billions to develop new drugs. It’s not satisfied. So it’s launching a startup"

Leave a comment

Your email address will not be published.